The company participated in Boston in an orientation program to facilitate the presentation of its activity in the United States Market.

3P Biopharmaceuticals participated the last September 5th through the 6th in “Boston Landing,” a pilot program destined to facilitate the presentation of R&D and innovation activities and business development of biotechnology companies in the United States.